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A B S T R A C T
Chronic exposure to mouse allergen may contribute greatly to the inner-city asthma burden. We hypothesized
that reducing mouse allergen exposure may modulate the immunopathology underlying symptomatic pediatric
allergic asthma, and that this occurs through epigenetic regulation. To test this hypothesis, we studied a cohort
of mouse sensitized, persistent asthmatic inner-city children undergoing mouse allergen-targeted integrated pest
management (IPM) vs education in a randomized controlled intervention trial. We found that decreasing mouse
allergen exposure, but not cockroach, was associated with reduced FOXP3 buccal DNA promoter methylation,
but this was unrelated to mouse specific IgE production. This finding suggests that the environmental epigenetic
regulation of an immunomodulatory gene may occur following changing allergen exposures in some highly
exposed cohorts. Given the clinical and public health importance of inner-city pediatric asthma and the potential
impact of environmental interventions, further studies will be needed to corroborate changes in epigenetic
regulation following changing exposures over time, and determine their impact on asthma morbidity in
susceptible children.
1. Introduction
As many as 25–50% of inner-city children with asthma have
evidence of allergic sensitization to mouse (Matsui et al., 2006;
Ahluwalia et al., 2013). This trend suggests that chronic exposure to
mouse allergen may contribute greatly to the inner-city asthma burden,
particularly in the major metropolitan areas of the Northeastern United
States. The multi-faceted environmental intervention by the Inner-City
Asthma Study (ICAS) group, as well as others, has shown that successful
reduction of indoor allergens can lead to long-lasting decreases in
asthma symptoms, asthma exacerbations, missed school and disrupted
sleep in children (Morgan et al., 2004; Pongracic et al., 2008; Johnson
et al., 2009). Nonetheless, its ability to induce immune modulation is
unknown and has implications for understanding the natural course of
allergic asthma, identifying those at greater risk, and determining
optimal treatment.
Environmental epigenetic regulation may induce immune modula-
tion. This is supported by observations that measures of multiple
environmental toxicants, including air pollution and allergens, are
associated with altered inflammatory, allergic and regulatory gene
methylation (Nadeau et al., 2010; Niedzwiecki et al., 2012; Salam et al.,
2012). But far less studied are the impacts of potential changes in
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exposures over time on changes in epigenetic marks, and whether these
changes in epigenetic marks are clinically relevant. As an example,
human rhinovirus infection changed global methylation in nasal
epithelial cells to levels that varied by asthma diagnosis (McErlean
et al., 2014). In the Normative Aging Study of elderly men, changes in
particle numbers, levels of black carbon, and ozone over the preceding
4 weeks were associated with inflammatory gene specific changes in
DNA methylation (Bind et al., 2014). However, comparable studies of
changes in pediatric cohorts are scant. One exception is the Protection
Against Allergy: Study in Rural Environments (PASTURE) study that
observed significant differences in the DNA methylation of several
genes assessed in cord blood and then repeated at age 4.5 years. The
differences with aging during childhood also varied by whether there
was prenatal exposure to a farm environment, and by whether the child
was subsequently diagnosed with asthma (Michel et al., 2013).
To address this research gap, we measured prospectively and
repeatedly promoter DNA methylation and expression of targeted
asthma candidate genes associated with regulating allergy (T regulatory
gene forkhead box P3 gene (FOXP3), and allergy suppressive gene
interferon (IFN)γ). Methylation of both genes previously was found to
occur in association with ambient environmental exposures (Liu et al.,
2008; Brand et al., 2012; Kohli et al., 2012; Niedzwiecki et al., 2012;
Runyon et al., 2012; Tang et al., 2012) and with allergy and asthma (Liu
et al., 2008; Brand et al., 2012; Runyon et al., 2012). We utilized
pyrosequencing to capture and quantify small differences predicted to
underlie potential changes in the exposure-outcome relationships
(Murphy et al., 2012; Michel et al., 2013; Richmond et al., 2015;
Clifford et al., 2017). This observational substudy combined measures
from mouse sensitized, moderate to severe asthmatic inner-city children
(n=200; 6–17yr) undergoing mouse allergen-targeted integrated pest
management (IPM) vs education in a randomized control intervention.
We sampled buccal cells that comprise the aerodigestive track epithe-
lium because they are accessed easily in children (Breton et al., 2011;
Kuriakose et al., 2011; Lovinsky-Desir et al., 2014), and undergo
molecular alterations following environmental exposures (Bhutani
et al., 2008; Salam et al., 2012; Wan et al., 2014), and in association
with airway inflammation (Breton et al., 2011; Salam et al., 2012). We
postulated that reducing allergen exposure would modulate the im-
munopathology underlying persistent pediatric allergic asthma through
epigenetic regulation. Specifically, we hypothesized that changes in
mouse allergen exposure would be associated with changes in buccal
cell methylation and expression, and that these would alter mouse-
specific immunoglobulin (Ig)E.
2. Materials and methods
Children with persistent asthma and an exacerbation in the previous
year underwent measurement of home settled bed dust and bed floor
dust for mouse allergen (Mus m 1) and bed dust for cockroach (Bla g2)
and dust mite allergen (Der f 1) by ELISA (Indoor Biotechnologies,
Charlottesville, VA). Mouse-specific IgE (against mouse urine proteins,
e72) was tested by Immunocap (ThermoFisher, Uppsala, Sweden) as
described (Matsui et al., 2006; Sedaghat et al., 2016). Mouse exposed
(determined by bed dust mouse allergen concentration of≥0.4 µg/g or
a bedroom floor dust mouse allergen concentration of ≥0.5 µg/g) and
sensitized children were enrolled in a home-based Mouse Allergen and
Asthma Intervention Trial (MAAIT; Fig. 1) (Sedaghat et al., 2016). The
pest management education that was delivered as a control included
information about setting mouse traps, sealing holes and cracks, and
housekeeping practices. The IPM was delivered in treatments. The first
treatment included targeted cleaning to remove allergen reservoirs,
placement of traps, application of rodenticide, sealing holes and cracks,
installation of allergen-proof mattress and pillow encasements (Clean-
Brands, LLC, Warwick, Rhode Island), and two portable air purifiers
(Filtrete™ Room Air Purifier, 3M, St. Paul, Minnesota). This was
followed by a visit 1–2 weeks later to reset traps and complete any
work remaining from the primary visit. Each treatment was delivered
by a licensed pest technician and by study staff.
Extracted DNA underwent bisulfite conversion and pyrosequencing
of the upstream enhancer (FOXP3 only) and promoter (both genes)
areas (Lovinsky-Desir et al., 2014). The FOXP3 CpG loci within the gene
promoter area were selected based on our previous associations with
Treg function and asthma (Runyon et al., 2012) and their relatively
large range in methylation levels across individuals (data not shown).
The IFNγ CpG loci within the gene promoter were selected based on
their conservation in mice (Niedzwiecki et al., 2012; Collison et al.,
2013), specific roles in regulating gene expression (Gonsky et al., 2009;
Brand et al., 2012; Kohli et al., 2012; Belsky et al., 2013), susceptibility
to allergen and air pollution (Liu et al., 2008; Brand et al., 2012;
Niedzwiecki et al., 2012), and previously implicated role in allergy and
asthma (Kohli et al., 2012; Runyon et al., 2012).
Total RNA was extracted using Trizol (Molecular Research Center,
Inc., Cincinnati, OH; Supplemental Tables 1A,B). qRT-PCR was carried
out using the SuperScript First-Strand Synthesis System and the Applied
Biosystems® 7500 Real-Time PCR Systems. The housekeeper gene
cystatin A (CSTA) was selected based on its high and specific expression
in the buccal mucosa (Magister and Kos, 2013). Mouse and cockroach
allergen levels and buccal cells were collected at baseline and 6 months
later. Dust mite allergen levels were collected at baseline only. Mouse
IgE was assessed at baseline and 12 months later. The study was
approved by the Institutional Review Boards of Columbia University
Medical Center, Johns Hopkins University, and Harvard University.
The distribution of each variable was examined and an appropriate
transformation was applied as necessary to meet parametric model
assumptions. Analyses were conducted separately for each CpG gene
site. Allergen levels and RNA values were natural log transformed.
Values (eg, mouse allergen) below a limit of detection (LOD) were
assigned a value at half the LOD. Methylation levels within the FOXP3
enhancer highly correlated with each other (Spearman correlation
coefficients 0.90–0.94) at each visit, and in subsequent analyses the
average of the 4 values were used as a single variable.
The signed rank test was used to compare differences in allergen and
mouse IgE levels between visits. The Kruskal-Wallis test was to used to
detect bivariate associations between the methylation or gene expres-
sion levels and categorical variables including sex, site (Boston, Boston
Children's Hospital, Harvard Medical School; Baltimore, Johns Hopkins
University), race/ethnicity, insurance type, any reported exposure to
second hand smoke, maternal allergy status and particulate matter less
than 10 µm or not, at each visit. The spearman correlation coefficient
was used to indicate bivariate association between quantitative vari-
ables, specifically the correlations among individual buccal biomarkers
and between the arithmetic change in allergen and change in methyla-
tion. To examine concurrent associations between mouse allergen and
Fig. 1. Study algorithm. The IPM group received two IPM visits at 0.5 and 1.5 months
(solid arrows). If there was evidence of mouse infestation at 3, 6, and 9 months, a
subsequent IPM visit occurred at 3.5, 6.5 (see dashed arrows) and 9.5 months (not
shown). The second mouse IgE level was measured at 12 month time-point, in contrast to
the allergen (Mus m 1, Bla g 2) and epigenetic biomarkers, each measured at baseline and
6.0 months.
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each of the methylation or gene expression outcome variables with
repeated measures over time, we used marginal linear models with
mouse allergen as the predictor. The generalized estimating equations
(GEE) approach, taking into account within-person correlation in
repeated measures, was used to estimate model parameters and make
statistical inference. Because a sex difference in the FOXP3 enhancer
and association between age and gene expression was evident, we
controlled for sex (age) in the marginal models. To determine whether a
decrease in mouse (or cockroach) allergen changed FOXP3 or IFNγ
methylation or gene expression, linear regression models were built
with the change in the methylation or gene expression as the dependent
variables, and the change in mouse (or cockroach) allergen as the
primary independent variable. Models were controlled for mouse
allergen, CpG methylation or gene expression at baseline. Sex and age
were not related to the change in FOXP3 or IFNγmethylation over time,
so the models exhibited in Tables 2 and 3 controlled only for baseline
levels. Linear models were used to examine whether a change in
methylation (over 6 months) was associated with a change in mouse
IgE (over 12 months), controlling for mouse–specific IgE and CpG
methylation or gene expression at baseline.
3. Results and discussion
Participant baseline characteristics are displayed in Table 1. The age
of the participants ranged 5.2–17.5 years (mean 9.7±3.4 standard
deviation (SD)). The average number of positive skin tests in addition to
mouse was 4.7±2.8. In our cohort of n=200, similar to that
previously published (Matsui et al., 2017), mouse allergen in the bed
(median 0.9, IQR 2.7 to median 0.6, IQR 1.3, p< 0.0001) and floor
(median 4.2, IQR 16.0 to median 1.8, IQR 6.4, p< 0.0001), and
cockroach allergen in the bed (median 0, IQR 0.02 to median 0, IQR
14.7, p=0.04), decreased overall between visits. Also, in our subset of
n=187 with paired data for mouse IgE analyses, similar to what we
previously published (Matsui et al., 2017), mouse IgE decreased overall
(median 10.7 kU/L, IQR 33.9 to median 7.0, IQR 22.6, p< 0.0001).
Boys had lower baseline buccal DNA methylation than girls at the
FOXP3 enhancer at both visits (mean± SD: visit 1-boys: 4.96± 5.38%
vs. girls: 40.59±7.61%; visit 2-boys 4.39± 5.01 vs. girls:
41.02±6.11; p<0.0001 for both visits). Baseline sex effects were
apparent in the opposite direction at the two FOXP3 promoter sites
(mean± SD FOXP3 CpG−138: visit 1-boys: 66.38± 11.28% vs. girls:
46.03±11.03%; visit 2-boys: 69.12±12.57 vs girls: 47.40±10.70;
p<0.0001 at both visits; mean± SD CpG−126: visit 1-boys:
86.15±7.10% vs. girls: 82.67± 8.25%, p=0.003; visit 2-boys:
88.28±7.38 vs. girls: 84.23.40± 6.60, p<0.0001). Significant sex
effects for IFNγ were not observed. FOXP3 and IFNγ gene expression
were associated inversely with age at visit 1 only (Spearman correlation
Table 1
Participant baseline characteristics (n=200).
Number %
Site Baltimore (vs. Boston) 168 84
Income<$25,000 annual 117 58.5




Public medical insurance 178 89.0









The age of the participants ranged 5.2–17.5 years (mean 9.7± 3.4 standard deviation
(SD)).
* Defined as any smoker in the home.
** Based on maternal report.
Table 2
The association between the change in mouse allergens over time and change in FOXP3 and IFNγ promoter methylation.
Outcome: change in FOXP3 Outcome: change in IFNγ
Enhancer CpG−138 CpG−126 Expression CpG−186 CpG−54 Expression
n 191 198 198 198 186 186 198
B (SE) B (SE) B (SE) B (SE) B (SE) B (SE) B (SE)
Mouse allergen predictor Bed dust −0.15 1.78* −0.45 0.16 −0.33 0.30 0.04
(0.37) (0.70) (0.37) (0.10) (0.40) (0.37) (0.09)
Bed floor dust −0.25 0.90 −0.25 0.09 −0.51 0.36 0.05
(0.32) (0.60) (0.31) (0.08) (0.33) (0.31) (0.07)
B: Estimated regression coefficient
SE: Standard error.
Enhancer defined as average methylation at CpG−4506, CpG−4500, CpG−4494, CpG−4484.
Relative expression of FOXP3 was measured using log transformation (variable+0.1).
Relative expression of IFNγ was measured using log transformation (variable+0.5).
Analyses controlled for both mouse allergen at baseline (natural log transformed) and CpG methylation or gene expression at baseline. Sensitivity analyses of gene expression including




Change in methylation and expression over 6 month was not associated with change in
mouse IgE over 12 month.
Change in FOXP3 Enhancer CpG−138 CpG−126 Expression
B −0.01 −0.01 −0.02 −0.03
SE 0.01 0.004 0.01 0.03
Change in IFNγ CppG-186 CpG-54 Expression
B −0.002 0.004 0.02
SE 0.01 0.01 0.04
B: Estimated regression coefficient. SE: Standard error
Relative expression of FOXP3 was measured using log transformation (variable+0.1)
Relative expression of IFNγ was measured using log transformation (variable+0.5)
Analyses controlled for both mouse allergen at baseline (natural log transformed) and
CpG methylation or gene expression at baseline. Sensitivity analyses of gene expression
including only those with qRT-PCR cycle length<37 did not alter the results.
N=179 for all analyses, with specimens excluded due to lack of 12 month blood specimen
(n=12 samples from 11 individuals), or inadequate or pyrosequencing reactions failed
(up to n=15 for IFNγ methylation analyses).
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coefficient r=−0.19, r=−0.22 respectively, p< 0.05; Supplemental
Table 2). Methylation at IFNγ CpG−186 also was lower with age
((r=−0.18, p=0.02) at visit 2, Supplemental Table 2)).
Using marginal models that accounted for within-subject correlation
in repeated measures, higher levels of mouse allergen in bed dust were
associated with lower methylation in the FOXP3 promoter at CpG−126
(Estimated regression coefficient B=−0.62, p=0.004), but not buccal
DNA methylation at other sites or regulatory gene expression. None of
the methylation variables were associated with mouse-specific IgE.
In prospective analyses of the changes in methylation or gene
expression levels between study visits, we found the opposite associa-
tion between allergen and methylation. Decreases in mouse allergen in
the bed dust borderline correlated with decreases in methylation at the
FOXP3 enhancer sites (r=0.14, p=0.05). Further, to assess whether
change in mouse allergen over time predicted change in DNA methyla-
tion, regression models were run that controlled for baseline levels of
mouse allergen in the bed. We found that decreases in mouse allergen
predicted decreases in FOXP3 promoter methylation, in this case at the
CpG−138 site (estimated regression coefficient B=1.78, p=0.01,
Table 2). Controlling for FOXP3 CpG−138 and mouse allergen level at
baseline, a 50% reduction of mouse allergen in bed dust was associated
with mean reduction of 1.23% methylation in FOXP3 CpG−138.
In addition, we restricted the analyses to only those with undetect-
able dust mite allergen at baseline and we found the same association
between change in mouse allergen and change in methylation, suggest-
ing that there was not confounding by dust mite allergen. We reran the
main models using cockroach allergen (Bla g 2 in bed dust) as the
predictor on the same epigenetic outcomes. No significant association
between the change in cockroach allergen over time and change in DNA
methylation were detected, with and without further control for mouse
allergen variable at baseline. Adding the cockroach variable at baseline
did not significantly alter the associations between change in mouse
allergen over time with the change in DNA methylation. We also did not
find any significant changes in gene expression, including during
sensitivity analyses that excluded any samples that required a high
number of cycles to amplify (i.e, those with presumed very small
amounts of RNA) (Table 2).
In further analyses, the changes in FOXP3 and IFNγmethylation and
expression over the 6 month sampling period were not associated with
a change in mouse IgE during these same 6 months plus 6 months
afterwards (i.e. by the 12 month period; Table 3). These results suggest
that these examples of DNA methylation did not induce sustained
effects on mouse sensitization. In addition, the change in the mouse
allergen in the bed was not associated directly with a change in mouse
IgE levels over time. This latter finding contrasts with that from the
parent study (Matsui et. al., 2017) that used random effects model and
repeat measures of IgE, a different period for change in mouse allergen
(6 vs 12 mo), and a larger sample.
Quantifying small differences in specific CpG targets allows us to
compare methylation levels across sites. Of the two neighboring FOXP3
promoter sites (CpG−126, CpG−138), while positively correlated with
each other, correlated negatively with CpG methylation levels in the
FOXP3 enhancer (Supplemental Table 3). Buccal methylation levels at
the FOXP3 CpG−126 site correlated negatively and weakly with IFNγ
gene expression at visit 2 only. Buccal methylation at IFNγ CpG−54 and
IFNγ CpG−186 correlated positively and weakly with IFNγ relative gene
expression, also only at visit 2.
Overall, these findings suggest that a reduction in mouse allergen,
but not cockroach, observed in the setting of IPM vs education
intervention trial may have reduced FOXP3 promoter DNA methylation.
The decrease in FOXP3 methylation in buccal cells may be consistent
with upregulated T suppressive activity, presumably following activa-
tion of the FOXP3 gene; although, this was not detected in the buccal
RNA. These findings with respect to methylation point to the gene
regulatory effects of reducing allergen levels, albeit small, even if there
was not a statistically significant effect on mouse specific IgE.
We also identified a strong effect of sex on buccal methylation level
in the FOXP3 enhancer. The levels of FOXP3 methylation in the
enhancer region in males were markedly lower than in females. In
contrast, the sex-related differences were less marked in the FOXP3
promoter, and in the opposite direction. The significance of these
differences is uncertain, but one could speculate that it relates to
epigenetic regulation of X-chromosome inactivation (XCI). For exam-
ple, female cells undergo XCI, and DNA methylation of the inactive X is
known to contribute to the maintenance of its inactive state; levels of
methylation within a gene silenced by XCI can vary by region.
Specifically, levels of promoter methylation of genes silenced by XCI
have been correlated with susceptibility to XCI, and CpG islands tend to
be sites where there is greater methylation on the inactivated X
chromosome compared to other areas (Sharp et al., 2011). Because
the FOXP3 gene is subject to XCI (Tommasini et al., 2002), one could
speculate that the higher methylation levels measured in the FOXP3
enhancer of females in this cohort reflects regulation by DNA methyla-
tion of XCI to some extent. Although this speculation would not explain
the lower methylation levels found in females in the FOXP3 promoter
region, other than demonstrating that variation in methylation levels
across genes applies to genes silenced by XCI (Sharp et al., 2011).
In comparison, we previously found that methylation at the IFNγ
promoter varied by sex in CD4+ lymphocyte but not buccal cell DNA
(Lovinsky-Desir et al., 2014). Here too the underlying mechanism still
needs to be elucidated. For both genes, differences in hormone levels or
unmeasured environmental exposures that vary by behaviors among
boys and girls also may explain differential induction of DNA methyla-
tion. The sex differences in FOXP3 we observed suggest that sex effects
on methylation, including its variation by CpG region, should be
considered when designing studies of epigenetic biomarkers in asthma.
These findings support the premise that during an intervention
against mouse allergen, the changing environment over time may drive
some plasticity in the level of the DNA methylation, as reported in other
studies (Bind et al., 2014; Borsch-Haubold et al., 2014; McErlean et al.,
2014). The direction of these results appear different than observed in
one report in pollen-allergic patients where local challenge of the nasal
mucosal with pollen extract led to an increase in the FOXP3 expressing
T cells (Skrindo et al., 2011). But other studies have not examined
epigenetic regulation in symptomatic children following chronic, daily
allergen exposure. Further, it could be consistent with other environ-
mental exposures like respiratory syncytial virus infection that reduced
T reg function, thereby promoting susceptibility to allergic asthma
(Krishnamoorthy et al., 2012). We believe these associations are gene
specific as there is substantial evidence that epigenetic regulation of
both FOXP3 and IFNγ is associated with clinically relevant outcomes
(Liu et al., 2008; Brand et al., 2012; Kohli et al., 2012; Niedzwiecki
et al., 2012; Runyon et al., 2012; Tang et al., 2012). There is more
limited evidence to suggest that differences in global methylation
instead may explain outcomes related to exposure to cigarettes and
air pollution (Breton et al., 2009, 2016; Lee et al., 2015) and allergic
sensitization (Sordillo et al., 2013) in some, but not other (Chi et al.,
2016), studies.
Hence, with this prospective and repeat sampling design, we may
have identified novel conditions for which a change in the indoor
environment altered the promoter methylation profile of an immunor-
egulatory gene, in this case suggesting that the maintenance of T
regulatory function may have become further upregulated. The results
may reveal that highly exposed, allergic and asthmatic children could
be resistant to usual allergen-induced regulatory mechanisms due to
undefined molecular impairments (Yamamoto et al., 2011), or the
contribution of other genes or CpG sites within the same genes, or even
other epigenetic pathways like histone acetylation or hydroxymethyla-
tion (Planell-Saguer et al., 2014). However, the results also do not
support the paradigm that decreased FOXP3 methylation is part of the
causal pathway leading to changes in mouse IgE, at least according to
this timeline for a clinical allergic response. Rather, FOXP3 methylation
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may act more as a marker of effective changes in allergen exposure, or
potentially of functional changes in other immune cells.
The relevance of the expression of FOXP3 and IFNγ in the buccal
mucosa described here and elsewhere (Scadding et al., 2010), and their
exact roles following allergen remediation, are still not elucidated from
these results. FOXP3 methylation, perhaps because it may capture
changes over a longer time period than buccal gene expression, may
contribute more to the immune response to changed allergen exposure.
Indeed, altered buccal DNA methylation has been associated with
airway inflammation in previous pediatric cohorts (Breton et al.,
2011). Striking variation by CpG site within the promoter was detected
and may suggest that individual CpG site may function independently,
as reported (Clifford et al., 2017). The marginal models with repeated
measures that demonstrated patterns opposite to our prospective
findings may have been susceptible to bias due to unmeasured
confounding factors. Nonetheless, we also acknowledge that the effect
sizes were generally small and we were working with a mixed
population of cells. Buccal epithelial cells were used in large part
because the process of obtaining them is noninvasive, which is critical
in pediatric cohorts studies. We do not yet know whether the changes
are universal or similar across tissues, as several asthma studies have
shown differences in some gene methylation patterns by cell type
(Stefanowicz et al., 2012; Lovinsky-Desir et al., 2014). But buccal cells
have revealed epigenetic patterns relevant to allergy, when collected
using comparable techniques (Breton et al., 2011; Kuriakose et al.,
2011; Salam et al., 2012; Lovinsky-Desir et al., 2014). Our focus on the
cytokine profile in buccal epithelial cells is novel, so additional studies
would be beneficial to understand more fully their translation. More-
over, cockroach allergen was detected only in 25% of the homes at
baseline, with borderline significant decreases over time. This observa-
tion, plus our analyses suggesting that this relatively infrequent
exposure did not predict epigenetic outcomes, makes confounding by
cockroach allergen less likely.
In conclusion, the longitudinal assessment of DNA methylation in
this unique pediatric cohort suggests that changing environmental
exposure can induce epigenetic regulation, and T suppressive activity
may even increase when high levels of mouse allergen are diminished.
They also support the epidemiological paradigm that findings in cross-
sectional analyses may not replicate under prospective evaluations. Our
results place us one step further towards understanding immunoregula-
tion and its susceptibility to change following changes in environmental
exposures. Given the high public health burden associated with
frequent sensitization to mouse in inner city asthma (Matsui et al.,
2006; Ahluwalia et al., 2013), these results may provide a foundation
for pursuing the hypothesis further that allergen interventions have the
potential to modify the natural course of disease among susceptible
children through epigenetic mechanisms.
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